Article Text

PDF

Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study
  1. William T Gattrell1,2,
  2. Sally Hopewell3,
  3. Kate Young4,
  4. Paul Farrow1,
  5. Richard White1,2,
  6. Elizabeth Wager5,6,
  7. Christopher C Winchester1,7
  1. 1Research Evaluation Unit, Oxford PharmaGenesis Ltd, Oxford, UK
  2. 2Department of Mechanical Engineering and Mathematical Sciences, Oxford Brookes University, Oxford, UK
  3. 3Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK
  4. 4Research Evaluation Unit, Oxford PharmaGenesis Inc, Newtown, Pennsylvania, USA
  5. 5Sideview, Princes Risborough, UK
  6. 6University of Split School of Medicine, Split, Croatia
  7. 7School of Medicine, Pharmacy and Health, Durham University, University Boulevard, Stockton-on-Tees, UK
  1. Correspondence to Dr William T Gattrell; will.gattrell{at}pharmagenesis.com

Abstract

Objectives Authors may choose to work with professional medical writers when writing up their research for publication. We examined the relationship between medical writing support and the quality and timeliness of reporting of the results of randomised controlled trials (RCTs).

Design Cross-sectional study.

Study sample Primary reports of RCTs published in BioMed Central journals from 2000 to 16 July 2014, subdivided into those with medical writing support (n=110) and those without medical writing support (n=123).

Main outcome measures Proportion of items that were completely reported from a predefined subset of the Consolidated Standards of Reporting Trials (CONSORT) checklist (12 items known to be commonly poorly reported), overall acceptance time (from manuscript submission to editorial acceptance) and quality of written English as assessed by peer reviewers. The effect of funding source and publication year was examined.

Results The number of articles that completely reported at least 50% of the CONSORT items assessed was higher for those with declared medical writing support (39.1% (43/110 articles); 95% CI 29.9% to 48.9%) than for those without (21.1% (26/123 articles); 95% CI 14.3% to 29.4%). Articles with declared medical writing support were more likely than articles without such support to have acceptable written English (81.1% (43/53 articles); 95% CI 67.6% to 90.1% vs 47.9% (23/48 articles); 95% CI 33.5% to 62.7%). The median time of overall acceptance was longer for articles with declared medical writing support than for those without (167 days (IQR 114.5–231 days) vs 136 days (IQR 77–193 days)).

Conclusions In this sample of open-access journals, declared professional medical writing support was associated with more complete reporting of clinical trial results and higher quality of written English. Medical writing support may play an important role in raising the quality of clinical trial reporting.

  • Randomised controlled trials
  • CONSORT
  • Medical writing
  • Quality
  • Peer review

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.